These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1356778)
21. [Role of urapidil in the treatment of arterial hypertension]. Ol'binskaia LI; Vertkin AL; Gogin EE; Zadionchenko VS; Martynov AI; Martynov IV; Kolassa N; Man int Vel'd AI; Sidorenko BA; Belova EV Kardiologiia; 1992 Apr; 32(4):99-111. PubMed ID: 1357221 [No Abstract] [Full Text] [Related]
22. Labetolol--combined alpha and beta blockade for hypertension. Raftery EB Scott Med J; 1978 Oct; 23(4):279-80. PubMed ID: 31683 [No Abstract] [Full Text] [Related]
23. Clinical Pharmacology of Alpha-1 Blockers Improving Drug-profile through Novel Formulations. Nerurkar RP; Ved JK J Assoc Physicians India; 2014 Sep; 62(9 Suppl):9-12. PubMed ID: 26245036 [TBL] [Abstract][Full Text] [Related]
24. Antihypertensive drugs: proposed sites and mechanisms of action. Kaplan HR; Smith RD Fed Proc; 1981 Jun; 40(8):2268-74. PubMed ID: 6113170 [No Abstract] [Full Text] [Related]
25. [Pharmacology of a new antihypertensive agent, metazosin (Kenosin)]. Trcka V; König J; Mácová S; Smíd M; Helfert I; Votavová M; Remesová J; Nezádalová E Cesk Farm; 1990 Jul; 39(6):266-74. PubMed ID: 1981860 [TBL] [Abstract][Full Text] [Related]
26. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
28. Advances in the management of hypertension: focus on terazosin, a new alpha1-adrenergic antagonist. May 3-5, 1985, Boca Raton, Florida. Am J Med; 1986 May; 80(5B):1-105. PubMed ID: 2872798 [No Abstract] [Full Text] [Related]
29. Urapidil in the treatment of hypertension. Rosendorff C Drugs; 1988; 35 Suppl 6():188-92. PubMed ID: 3042358 [TBL] [Abstract][Full Text] [Related]
30. Central and peripheral hypotensive activity of urapidil and its M1 and M2 metabolites in the cat. Boss H; Boer R; Beller KD; Sanders KH Drugs; 1990; 40 Suppl 4():34-7. PubMed ID: 1982652 [No Abstract] [Full Text] [Related]
31. Propranolol as an antihypertensive agent. Prichard BN Am Heart J; 1970 Jan; 79(1):128-33. PubMed ID: 4391325 [No Abstract] [Full Text] [Related]
33. [Fundamental research--a basis for the synthesis of new hypotensive drugs]. Almazov VA; Shliakhto EV Kardiologiia; 1991 Dec; 31(12):24-8. PubMed ID: 1687751 [TBL] [Abstract][Full Text] [Related]
34. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade. Constantine JW; Lebel W; Weeks R J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597 [TBL] [Abstract][Full Text] [Related]
35. Urapidil. A reappraisal of its use in the management of hypertension. Dooley M; Goa KL Drugs; 1998 Nov; 56(5):929-55. PubMed ID: 9829161 [TBL] [Abstract][Full Text] [Related]
36. Influence of urapidil and other antihypertensive agents on lipids and glucose metabolism in hypertensive patients. Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Spinazzi A; Zanchetti A Eur Heart J; 1992 Jun; 13 Suppl A():61-4. PubMed ID: 1396851 [No Abstract] [Full Text] [Related]
37. Ergometry as a basis for judging the antihypertensive effect. Franz IW; Tönnesmann U; Erb D; Ketelhut R Drugs; 1990; 40 Suppl 4():54-7. PubMed ID: 2092968 [No Abstract] [Full Text] [Related]
38. [Urapidil in primary arterial hypertension]. Román O; Sudy E; Gac JC; Valenzuela MA Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026 [No Abstract] [Full Text] [Related]